Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Thế giới
(Baothanhhoa.vn) - Theo thông báo của Bộ Tài chính Israel, chi phí từ xung đột giữa Israel và Iran đang gia tăng nhanh chóng, với ước tính chi phí trực tiếp từ xung đột với Iran kể từ cuối tháng 2/2026 đã lên tới khoảng 35 tỷ shekel (tương đương 11,5 tỷ USD).
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh